Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 3, 2009, Pages 244-247

  Powers, J H ^a   Fleming, T R ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; LINEZOLID; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL PNEUMONIA; CELLULITIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INCISION; INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NOSOCOMIAL PNEUMONIA; NOTE; ORGANISM; PATHOGENESIS; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURGICAL DRAINAGE; TREATMENT DURATION; TREATMENT RESPONSE; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RESEARCH DESIGN; STAPHYLOCOCCAL INFECTIONS;

EID: 69449087037     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.132     Document Type: Note

References (10)

1. Powers, J.H. Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin. Infect. Dis.45 (suppl.2), S153-S162 (2007).
2. Wang, R., Lagakos, S.W., Ware, J.H., Hunter, D.J. & Drazen, J.M. Statistics in medicine - reporting of subgroup analyses in clinical trials. N. Engl. J. Med. 357, 2189-2194 (2007). (Pubitemid 350146117)
3. Wunderink, R.G., Rello, J., Cammarata, S.K., Croos-Dabrera, R.V. & Kollef, M.H. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124, 1789-1797 (2003). (Pubitemid 37433574)
4. Rubinstein, E., Cammarata, S., Oliphant, T. & Wunderink, R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin. Infect. Dis. 32, 402-412 (2001). (Pubitemid 32173626)
5. Wunderink, R.G., Cammarata, S.K., Oliphant, T.H. & Kollef, M.H. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin. Ther. 25, 980-992 (2003).
6. Fleming, T.R. & Powers, J.H. Issues in noninferiority trials: the evidence in community-acquired pneumonia. Clin. Infect. Dis. 47 (suppl.3), S108-S120 (2008).
7. Klompas, M. Does this patient have ventilator-associated pneumonia? JAMA 297, 1583-1593 (2007). (Pubitemid 46588372)
8. Carroll, K.C. Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status. Mol. Diagn. Ther. 12, 15-24 (2008).
9. Gillings, D. & Koch, G. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Information J. 25, 411-424 (1991).
10. Yusuf, S., Wittes, J., Probstfield, J. & Tyroler, H.A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266, 93-98 (1991).